Disability News and Research

RSS

Report: One in two Americans affected by musculoskeletal condition

An estimated 126.6 million Americans (one in two adults) are affected by a musculoskeletal condition--comparable to the total percentage of Americans living with a chronic lung or heart condition--costing an estimated $213 billion in annual treatment, care and lost wages, according to a new report issued today by the United States Bone and Joint Initiative.

2 Mar 2016

CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

The Centre for Addiction and Mental Health and Impel NeuroPharma have signed a licensing agreement to advance a new neuropeptide-based therapeutic approach shown to be effective in treating depression.

1 Mar 2016

Osteopathic manipulative treatment improves function in patients suffering from chronic low back pain

Studies published in the Journal of the American Osteopathic Association found that osteopathic manipulative treatment (OMT) reduced pain and improved function in patients suffering from chronic, nonspecific low back pain.

1 Mar 2016

Are we ageing healthily? An interview with Professor Carol Jagger

This is the million dollar question but it is hard to give a definite answer. Most data on trends in life and healthy life expectancy use surveys that do not include people in care homes which can skew results at older ages.

29 Feb 2016

Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients

Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).

27 Feb 2016

Novel therapeutic approach to target monomeric Tau protein

Dementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in the human brain. These diseases represent one of the leading causes of death and disability in the elderly population in the western world, with no current effective therapy.

27 Feb 2016

Immune-suppressing drug can improve cognitive ability of patients with schizophrenia

A recent study of a handful of patients supports mounting evidence that targeted suppression of inflammation packaged with standard therapy can improve the cognitive ability of patients with schizophrenia, physician-scientists report.

25 Feb 2016

Does simulated based training bring better value healthcare? An interview with Prof Sir Muir Gray, Former Chief Knowledge Officer of the NHS

We have to think of the world that we are leaving, the world we are moving into. The last fifty years in healthcare, have seen the advent of hip replacement, cardiac bypass, systematic reviews. But at the end of fifty years, every country is facing five problems.

24 Feb 2016

College psychology courses lack important information about disabilities

Psychology classes are among the most popular courses on college campuses today, but new research shows that many of them lack important information about the largest single minority group in the U.S. - people with disabilities.

24 Feb 2016

Black, white Americans cope with pain differently

Researchers led by Adam T. Hirsh of the School of Science at Indiana University-Purdue University Indianapolis report that black and white Americans cope with pain differently and that blacks employ pain coping strategies more frequently than whites. The IUPUI review and analysis of 19 studies is the first to examine the entire published literature and quantify the relationship between race and the use of pain-coping strategies.

23 Feb 2016

National Stroke Association reports positive outcomes from Stroke Recovery Navigator program

National Stroke Association released today the promising results from the pilot of its Stroke Recovery Navigator program (SRN) at the International Stroke Conference in Los Angeles.

23 Feb 2016

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

Reporting on the results of a phase III international clinical trial, Johns Hopkins Medicine physicians say use of a cardiac clot-busting drug to treat strokes that cause brain bleeding safely decreased the death rate in patients by 10 percent, compared to a control group receiving saline.

23 Feb 2016

MRI for unwitnessed stroke looking promising

Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.

22 Feb 2016

Differences in patient education level may compromise safety, efficacy of anticoagulants

Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association / European Society of Cardiology survey published today in Europace.

22 Feb 2016

Excessive growth of bacteria in small intestine could lead to stunting in young children

Excessive growth of bacteria in the small intestine could be damaging the guts of young children, leading to stunting, scientists from the U.S. and Bangladesh have discovered.

22 Feb 2016

Wearable robotic exoskeleton may enable multiple sclerosis patients to walk more efficiently

Walking with a wearable robotic exoskeleton may enable people with multiple sclerosis to walk more efficiently by reducing the energy and muscle activity needed to walk, according to research presented this week at the Association for Academic Physiatrists Annual Meeting in Sacramento, Calif.

19 Feb 2016

Clot-busting drugs decrease mortality in one of worst forms of hemorrhagic stroke

The use of clot-busting drugs to clear blood from the brain's ventricles may be the first effective strategy to decrease mortality for a type of catastrophic bleeding stroke, according to phase-3 clinical trial results announced Thursday at the International Stroke Conference in Los Angeles.

19 Feb 2016

Study finds that half the world's population to be short-sighted by 2050

Half the world's population (nearly 5 billion) will be short-sighted (myopic) by 2050, with up to one-fifth of them (1 billion) at a significantly increased risk of blindness if current trends continue, says a study published in the journal Ophthalmology.

18 Feb 2016

Motor skill training using exoskeleton device beneficial to people suffering from post-stroke weakness

Motor skill training using a robotic arm exoskeleton may be beneficial to people suffering from post-stroke weakness affecting an entire side of their body, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif.

18 Feb 2016

Early rehabilitation after traumatic spinal cord injury better for patients

Early rehabilitation following a traumatic spinal cord injury may lead to better functional outcomes for patients at the time of their discharge and in the subsequent year, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif.

18 Feb 2016

Disability News and Research

Report: One in two Americans affected by musculoskeletal condition

CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

Osteopathic manipulative treatment improves function in patients suffering from chronic low back pain

Are we ageing healthily? An interview with Professor Carol Jagger

Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients

Novel therapeutic approach to target monomeric Tau protein

Immune-suppressing drug can improve cognitive ability of patients with schizophrenia

Does simulated based training bring better value healthcare? An interview with Prof Sir Muir Gray, Former Chief Knowledge Officer of the NHS

College psychology courses lack important information about disabilities

Black, white Americans cope with pain differently

National Stroke Association reports positive outcomes from Stroke Recovery Navigator program

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

MRI for unwitnessed stroke looking promising

Differences in patient education level may compromise safety, efficacy of anticoagulants

Excessive growth of bacteria in small intestine could lead to stunting in young children

Wearable robotic exoskeleton may enable multiple sclerosis patients to walk more efficiently

Clot-busting drugs decrease mortality in one of worst forms of hemorrhagic stroke

Study finds that half the world's population to be short-sighted by 2050

Motor skill training using exoskeleton device beneficial to people suffering from post-stroke weakness

Early rehabilitation after traumatic spinal cord injury better for patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News